Court: U.S. Patent Office Patent Trial And Appeal Board
Date: Feb 17, 2015
Judge: Richard E. Rice
January 29, 2015 – Motion to reconsider Final Written Decision denied
December 3, 2014 – In a Final Written Decision, the Board found that Claims 1, 2, and 4-24 were not shown to be unpatentable.
February 4, 2014 – Based on the Board’s claim construction, the Board determined that there is a reasonable likelihood that Trivascular would prevail in showing unpatentability of certain claims. Therefore, the Board authorized institution of an inter partes review of those claims. However, the Board determined that there is not a reasonable likelihood that Trivascular would prevail in showing unpatentabiltiy of other claims, and therefore did not institute inter parties review of those other claims.
August 5, 2013 – TriVascular files a Petition for Inter Partes Review at the U.S. Patent Office alleging that all the claims in U.S. Patent No. 6,007,575 are unpatentable. The ‘575 patent is entitled “Inflatable Intraluminal Stent and Method for Affixing Same Within the Human Body.”
- Motion to Reconsider Denied [24.73 kB]
- Final Written Decision [505.64 kB]
- Institution of Inter Partes Review [427.16 kB]
- Petition [863.4 kB]
- U.S. Patent No. 6,007,575 [601.62 kB]